Related Experiment Videos
Experience on loading dose--quinine therapy in cerebral malaria
S R Mehta1, A I Lazar, A S Kasthuri
1Dept of Medicine, Armed Forces Medical College, Pune.
Summary
A loading dose of quinine (20 mg/kg) significantly speeds parasite clearance in cerebral malaria patients (Plasmodium falciparum) compared to conventional doses (10 mg/kg). Recovery times and safety profiles were similar between groups.
Area of Science:
- Infectious Diseases
- Parasitology
- Pharmacology
Background:
- Cerebral malaria, a severe Plasmodium falciparum complication, requires effective treatment.
- Quinine is a standard antimalarial, but optimal dosing for severe cases is debated.
Purpose of the Study:
- To compare the efficacy and safety of a loading dose versus a conventional dose of quinine in treating cerebral malaria.
Main Methods:
- A comparative study of 12 patients receiving a quinine loading dose (20 mg/kg) versus 11 patients receiving a conventional dose (10 mg/kg).
- Evaluated parasite clearance rate, recovery time, and adverse events including hypoglycemia and cinchonism.
Main Results:
- The loading dose group demonstrated a significantly faster parasite clearance rate.
- No significant differences were observed in recovery time to consciousness between the groups.
- Adverse events like hypoglycemia and cinchonism were comparable, with no significant hypotension or ECG changes.
Conclusions:
- A quinine loading dose is well-tolerated and effectively accelerates parasite clearance in Plasmodium falciparum cerebral malaria.
- This dosing strategy may offer an advantage in managing severe malaria by reducing parasite burden more rapidly.